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ABSTRACT 
Background: Aspirin use is known to reduce the recurrence of stroke. However, the clinical 
response to aspirin has been mixed. The rate of stroke recurrence whilst on aspirin treatment 
is still unacceptably high. A plausible explanation for this may be resistance to the effects of 
aspirin. The causes of aspirin resistance are manifold and multi-factorial. We conducted a 
study to investigate the prevalence rate of biochemical aspirin resistance in a cohort of 
aspirin-naïve stroke patients. We also sought to determine the inherent factors that may 
predispose towards the development of aspirin resistance. Method: This was a cross-sectional, 
observational study conducted on patients admitted to our centre with an acute stroke who 
were aspirin-naïve. The diagnosis of an acute stroke was confirmed by clinical history and 
brain imagi ng. Fifty consecutive patients were prospectively enrolled. Socio demographic 
data were collected and baseline blood investigations were performed. Patients were tested 
for biochemical aspirin resistance using Multiplate platelet analyser (Dynabyte, Munich, 
Germany) after 5 doses of aspirin, corresponding to a total dose of 900 mg. Results: The 
median age of patients was 65.5 years and 54 % of patients were female. There were 11 
smokers; of these 10 were male. Twenty-six (52 %) patients were Chinese, 21 (41%) were 
Malay and 3 (6.0 %) were Indian. Aspirin resistance was present in 14 % of our 
patients.There was an inverse relationship between the presence of aspirin resistance and 
plasma HDL levels (r = -0.394; p = 0.005). There was no relationship observed between 
aspirin resistance and total cholesterol, triglycerides, LDL, HbA1c, ALT, ALP, urea and 
creatinine levels. There were no significant differences in demographic profiles or smoking 
status between the aspirin resistant and non-aspirin resistant groups. We did not find any link 
between ethnicity and aspirin resistance. Conclusions: Our results indicate that a lower HDL 
leve l is associated with biochemical aspi-rin resistance. This may increase platelet 
aggregation and consequently increase the risk of a recurrent stroke. The clinical implications 
for aspirin resistance are far reaching. Any evidence that correctable factors may negatively 
influence the action of aspirin warrants further investigation. The prevalence rate of 
biochemical aspirin resistance in our study is comparable to the findings in other studies 
performed in an Asian population. Further research is required to determine how our findings 
translate into clinical aspirin resistance and stroke recurrence.  
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